Battaglin F, O'Neil BH, Stintzing S, Ou FS, et al. Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance). Eur J Cancer 2025;227:115694.
PMID: 40803104